Shortage Watch Free FDA drug-shortage watch

← all medications

Benztropine Mesylate Injection

Brand names: Benztropine Mesylate

Category: Neurology

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Jan 27, 2026 · First posted: Jan 27, 2026 · 1 manufacturers, 1 listed presentations

As of Jan 27, 2026, the FDA lists Benztropine Mesylate Injection as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Benztropine Mesylate Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)
NDC 63323-970-02		 Fresenius Kabi USA, LLC Not specified Discontinuation of the manufacture of the drug

Related medications in shortage

Other Neurology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Benztropine Mesylate Injection (FDA data as of Jan 27, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Benztropine Mesylate Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Benztropine Mesylate Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/benztropine-mesylate-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).